Triumph Capital Management Increases Stake in Teladoc Health, Inc. (NYSE:TDOC)

Triumph Capital Management boosted its stake in shares of Teladoc Health, Inc. (NYSE:TDOC) by 11.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 19,154 shares of the health services provider’s stock after acquiring an additional 1,956 shares during the quarter. Triumph Capital Management’s holdings in Teladoc Health were worth $413,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Hexagon Capital Partners LLC raised its position in Teladoc Health by 204.4% during the fourth quarter. Hexagon Capital Partners LLC now owns 1,586 shares of the health services provider’s stock valued at $34,000 after acquiring an additional 1,065 shares in the last quarter. RIA Advisory Group LLC purchased a new position in Teladoc Health during the fourth quarter valued at approximately $36,000. GAMMA Investing LLC purchased a new position in Teladoc Health during the fourth quarter valued at approximately $41,000. Byrne Asset Management LLC purchased a new position in Teladoc Health during the third quarter valued at approximately $60,000. Finally, Van ECK Associates Corp grew its holdings in Teladoc Health by 20.3% in the fourth quarter. Van ECK Associates Corp now owns 3,589 shares of the health services provider’s stock valued at $77,000 after purchasing an additional 606 shares during the period. 76.82% of the stock is currently owned by hedge funds and other institutional investors.

Teladoc Health Stock Performance

NYSE TDOC opened at $12.81 on Thursday. The stock’s fifty day moving average is $14.48 and its two-hundred day moving average is $17.60. The firm has a market capitalization of $2.17 billion, a P/E ratio of -9.08 and a beta of 0.97. The company has a debt-to-equity ratio of 0.67, a quick ratio of 3.47 and a current ratio of 3.82. Teladoc Health, Inc. has a fifty-two week low of $12.53 and a fifty-two week high of $30.41.

Teladoc Health (NYSE:TDOC) last released its quarterly earnings data on Thursday, April 25th. The health services provider reported ($0.49) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.47) by ($0.02). Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.90%. The company had revenue of $646.13 million for the quarter, compared to analyst estimates of $637.31 million. During the same period last year, the firm posted ($0.37) EPS. The business’s quarterly revenue was up 2.7% on a year-over-year basis. On average, research analysts anticipate that Teladoc Health, Inc. will post -1.04 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several brokerages have commented on TDOC. Leerink Partnrs reissued a “market perform” rating on shares of Teladoc Health in a report on Monday, February 26th. DA Davidson dropped their price objective on Teladoc Health from $22.00 to $18.00 and set a “neutral” rating on the stock in a report on Wednesday, February 21st. Truist Financial lowered their price target on Teladoc Health from $23.00 to $17.00 and set a “hold” rating on the stock in a research note on Wednesday, March 6th. Wells Fargo & Company lowered their price target on Teladoc Health from $17.00 to $15.00 and set an “equal weight” rating on the stock in a research note on Monday. Finally, Citigroup lowered their price target on Teladoc Health from $21.00 to $19.00 and set a “neutral” rating on the stock in a research note on Wednesday, February 21st. Twelve research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $18.73.

Insider Buying and Selling at Teladoc Health

In other Teladoc Health news, insider Arnnon Geshuri sold 7,500 shares of Teladoc Health stock in a transaction on Monday, March 25th. The stock was sold at an average price of $15.06, for a total value of $112,950.00. Following the sale, the insider now owns 38,470 shares in the company, valued at $579,358.20. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In related news, insider Laizer Kornwasser sold 7,882 shares of the business’s stock in a transaction on Friday, February 2nd. The stock was sold at an average price of $19.18, for a total value of $151,176.76. Following the sale, the insider now owns 57,223 shares in the company, valued at approximately $1,097,537.14. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Arnnon Geshuri sold 7,500 shares of the business’s stock in a transaction on Monday, March 25th. The shares were sold at an average price of $15.06, for a total value of $112,950.00. Following the completion of the sale, the insider now owns 38,470 shares in the company, valued at approximately $579,358.20. The disclosure for this sale can be found here. Insiders have sold 135,441 shares of company stock worth $2,038,251 over the last quarter. 0.95% of the stock is currently owned by company insiders.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.